Gastrin agonists and antagonists

Pharmacology and Toxicology

Volumn 91, Issue 6, 2002, Pages 275-281

  Black, James W ^a   Kalindjian, S Barret ^a  

^a James Black Foundation   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 1 [2,3 DIHYDRO 2 OXO 1 PIVALOYLMETHYL 5 (2 PYRIDYL) 1H 1,4 BENZODIAZEPIN 3 YL] 3 [3 (METHYLAMINO)PHENYL]UREA; 1 [5 (3 AZABICYCLO[3.2.2]NON 3 YL) 2,3 DIHYDRO 1 METHYL 2 OXO 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; 2 NAPHTHALENE DERIVATIVE; 4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; 6 [[(1 ADAMANTYLMETHYL)AMINO]CARBONYL] 5 [[1 [[(3,5 DICARBOXYPHENYL)AMINO]CARBONYL] 2 PHENYLETHYLAMINO]CARBONYL]INDOLE; AG 041R; ASPERLICIN; BENZODIAZEPINE DERIVATIVE; BICYCLO COMPOUND; BUTYLOXYCARBONYLTETRAGASTRIN; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CHOLECYSTOKININ RECEPTOR STIMULATING AGENT; DEVAZEPIDE; DIBENZOBICYCLO[2.2.2]OCTANE; GASTRIN AGONIST; GASTRIN ANTAGONIST; GV 150013; IMIDAZOLE DERIVATIVE; ITRIGLUMIDE; JB 90118; JB 93242; JB 98248; LY 202769; N (4 BROMOPHENYL) 3 OXO 4,5 DIPHENYL 1 PYRAZOLIDINECARBOXAMIDE; NAPHTHALENE DERIVATIVE; PENTAGASTRIN; RP 73870; S 0509; UNCLASSIFIED DRUG; UNINDEXED DRUG; Z 360;

ANIMAL TISSUE; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; DRUG BIOAVAILABILITY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; FLUORESCENCE; MOLECULAR MODEL; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; GASTRINS; INDOLES; MICE; MODELS, MOLECULAR; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA;

EID: 0036965489     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2002.910602.x     Document Type: Conference Paper

References (20)

1. Anderson, J. C., M. A. Barton, R. A. Gregory, et al.: Antral hormone gastrin. Synthesis of gastrin. Nature 1964, 204, 933-934.
2. Bock, M. G., R. M. DiPardo, B. E. Evans, et al.: Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260. J. Med. Chem. 1989, 32, 13-16.
3. Chambers, M. S. & S. R. Fletcher: CCK-B antagonists in the control of anxiety and gastric acid secretion. Prog. Med. Chem. 2000, 37, 45-81.
4. Chang, R. S. L., V. Lotti, J. Monaghan, et al.: A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science 1985, 230, 177-179.
5. Gregory, H., P. M. Hardy, D. S. Jones, et al.: Antral hormone gastrin. Structure of gastrin. Nature 1964, 204, 931-932.
6. Gregory, R. A. & H. J. Tracy: The constitution and properties of two gastrins extracted from hog antral mucosa. Gut 1964, 5, 103-117.
7. Gregory, R. A. & H. J. Tracy: Isolation of two "big gastrins" from ZollingerEllison tumour tissue. Lancet 1972, 2, 797-799.
8. Hughes, J., P. Boden, B. Costall, et al.: Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 6728-6732.
9. Kalindjian, S. B., M. J. Bodkin, I. M. Buck, et al.: A new class of non-peptidic cholecystokinin-B/gastrin receptor antagonists based on dibenzobicyclo-[2.2.2]octane. J. Med. Chem. 1994, 37, 3671-3673.
10. Kalindjian, S. B., I. M. Buck, J. R. Cushnir, et al.: Improving the affinity and selectivity of a nonpeptide series of cholecystokinin-B/gastrin receptor antagonists based on the dibenzobicyclo[2.2.2]octane skeleton. J. Med. Chem. 1995, 38, 4294-4302.
11. Kalindjian, S. B., I. M. Buck, J. M. R. Davies, et al.: Non-peptide cholecystokininB/gastrin receptor antagonists based on bicyclic heteroaromatic skeletons. J. Med. Chem. 1996, 39, 1806-1815.
12. Kalindjian, S. B., D. J. Dunstone, C. M. R. Low, et al.: Nonpeptide cholecystokinin2 receptor agonists. J. Med. Chem. 2001, 44, 1125-1133.
13. Low, C. M. R., J. W. Black, S. B. Kalindjian, et al.: Development of peptide 3D structure mimetics: rational design of novel peptoid Cholecystokinin receptor antagonists. J. Med. Chem. 2000, 43, 3505-3517.
14. Martinez, J., M. Rodriguez, J. P. Bali & J. Laur: Phenethylamide derivatives of the C-terminal tetrapeptide of gastrin. Int. J. Pept. Prot. Res. 1986, 28, 529-535.
15. 2 receptor antagonists. Exp. Opin. Ther. Patents 2001, 11, 445-462.
16. Morley, J. S.: Synthesis of human gastrin (1) and the biological properties of analogues. Peptides 1967, 226-234.
17. Revel, L., L. Mennuni, O. Letari, et al.: Gastric acid antisecretive activity of CR2945, a new potent gastrin/CCKB receptor antagonist. Gut 1997, 41, (Suppl 3), Abstract P005.
18. Rodriguez, M., P. Dubreuil, J. P. Bali & J. Martinez: Synthesis and biological activity of partially modified retro-inverso pseudopeptide derivatives of the C-terminal tetrapeptide of gastrin. J. Med. Chem. 1987, 30, 758-763.
19. Tracy, H. J. & R. A. Gregory: Human gastrin-isolation, structure and synthesis isolation of two gastrins from human antral mucosa. Nature 1964, 204, 935-936.
20. Yu, M. J., K. J. Thrasher, J. R. McCowan, et al.: Quinazoline cholecystokinin-B receptor ligands. J. Med. Chem. 1991, 34, 1508-1511.